Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 13,874 shares at $76.45 ($1.1M) on 2021-09-10, disclosed to the SEC on 2021-09-13.
Open-market sale of $1.1M ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.45 | 900 | $69K | 6.4% |
| 2 | $77.69 | 5,029 | $391K | 36.2% |
| 3 | $77.69 | 5,029 | $391K | 36.2% |
| 4 | $78.31 | 1,458 | $114K | 10.6% |
| 5 | $78.31 | 1,458 | $114K | 10.6% |
| Total | $77.74 avg | 13,874 |
| $1.1M |
| 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |